Society for Clinical Research Sites & Medidata Launch Advisory Group in Support of Clinical Trial Investigators & Research Si...
October 10 2016 - 8:30AM
Business Wire
Forum Will Bring Together Stakeholders from
Across the Life Sciences Industry to Advance Important Dialogue on
Clinical Trial Management and Site Engagement
The Society for Clinical Research Sites (SCRS) and global
clinical trial technology and data analytics leader Medidata
(NASDAQ:MDSO) today announced the launch of a clinical trial Site
Advisory Group (SAG). The joint initiative aims to further efforts
to engage investigative sites throughout the course of a clinical
trial, a critical factor in ensuring successful patient enrollment
and high-quality data collection.
A key goal of the SAG will be to identify opportunities to
accelerate drug development and overcome operational challenges,
including streamlining the process used to reimburse investigative
sites for their work on trials—a major pain point in clinical
research today. According to an ongoing research project conducted
by the Clinical Trials Transformation Initiative (CTTI), lengthy
delays in payment result in high turnover rates among clinical
investigators, with 40 percent of sites dropping out of
FDA-regulated clinical trials. This high turnover rate drives up
the cost of drug development, with onboarding rates averaging
$40,000 per new site. The high turnover also results in sites
dropping out of clinical studies altogether.
“One of the most exciting components of our evolving partnership
with SCRS is continuing to hear directly from investigators about
their specific needs and perspectives on improving clinical trials,
now and in the future. We use this feedback to refine our
platform’s capabilities and develop solutions to address burdens in
the clinical trial process,” said April Mulroney, managing director
of Medidata’s site reimbursement technology, Medidata Payments.
“Investigative sites are vital to furthering scientific and medical
breakthroughs, and we want to ensure that they have the resources
and support needed to increase efficiencies, protect patient
safety, and ultimately, help get drugs to patients sooner.”
Medidata Payments is addressing the unmet need for modern
technology to automate the reimbursement process. Recently named a
2016 Scrip Awards finalist, Medidata Payments is the industry’s
only EDC-driven solution that generates accurate payment
calculations based on data gathered throughout a clinical study.
The solutions’ automatic trigger function takes the calculated
payments and feeds them into a disbursement system, sending funds
directly to sites upon completion of work and, as a result,
accelerates payment cycle times. In addition, Medidata Payments’
advanced global calculation capabilities adhere to desired currency
and country-specific tax requirements, further streamlining the
payment process by reducing time spent on financial reporting and
reconciliations.
“Medidata brings significant industry expertise, technology,
data, resources and insights to help drive improved strategic and
streamlined execution for clinical research,” said Christine
Pierre, President of SCRS. “By encouraging candid conversations
that bring together investigative sites, clinical trial sponsors,
CROs and other key industry organizations, Medidata is continuing
to help ensure that the voice of investigative sites is heard.
We’re excited to engage with Medidata to facilitate this important
dialogue, and look forward to working together to bring about
meaningful change for investigative sites and the industry at
large.”
Medidata, an integral member of SCRS’ Circle of Sustainability
program, will be a premier sponsor of next month’s Global Site
Solutions Summit as well as the inaugural European Site Solutions
Summit in early 2017. Glen de Vries, co-founder and president of
Medidata, will be a plenary speaker at the Global Site Solutions
Summit in Boca Raton, FL on October 13-16. A member of the SCRS
Global Impact Board, de Vries will present new insights on how to
improve site relationships.
Connect with Medidata:
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Medidata & @MySCRS
launch #clinicaltrial Site Advisory Group to spur industry
collaboration: http://ow.ly/CDoN304Yj53 #sitepayments
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
About SCRS
SCRS is a global trade organization founded in 2012 which
represents over 3,000 research sites in 49 countries. SCRS’ mission
is to unify the voice of the global clinical research site
community for greater site sustainability. SCRS has become an
active partner in industry-wide initiatives and dialogues focused
on improving the clinical research enterprise. Sites and the
companies that sponsor or support the work conducted at clinical
research sites will benefit from membership and partnership. Visit
MySCRS.org.
About Medidata
Medidata is reinventing global drug development by creating the
industry's leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences
customers worldwide, including more than 700 global pharmaceutical
companies, innovative biotech, diagnostic and device firms, leading
academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 17 of the world's
top 25 global pharmaceutical companies, from study design and
planning through execution, management and reporting.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161010005208/en/
Medidata:Medidata SolutionsInvestor:Anthony D’Amico, +1
732-767-4331adamico@mdsol.comorMedia:Nicole Pariser, +1
212-659-1069npariser@mdsol.comSCRS:Society for Clinical
Research SitesMary D’Rozario, +1
919-890-5513mary.drozario@myscrs.org
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Sep 2023 to Sep 2024